Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 1;27(8):e505-e509.
doi: 10.1097/RHU.0000000000001202.

Paraneoplastic Arthritides: Insights to Pathogenesis, Diagnostic Approach, and Treatment

Affiliations
Review

Paraneoplastic Arthritides: Insights to Pathogenesis, Diagnostic Approach, and Treatment

Konstantinos Parperis et al. J Clin Rheumatol. .

Abstract

Paraneoplastic arthritides are a group of inflammatory rheumatic syndromes induced by an occult and manifest malignancy, characterized by a wide range of musculoskeletal signs and symptoms that masquerade other rheumatic diseases such as rheumatoid arthritis. Although the pathogenesis of paraneoplastic arthritides is unknown, immune-mediated mechanisms can induce a paraneoplastic syndrome, with a dominant feature the polyarthritis. Common entities of paraneoplastic arthritides include paraneoplastic polyarthritis, hypertrophic osteoarthropathy, remitting seronegative symmetrical synovitis with pitting edema, palmar fasciitis and polyarthritis, and polyarthritis and panniculitis associated with pancreatic carcinoma. The electronic databases PubMed and Scopus were scrutinized using the following terms: paraneoplastic arthritis, paraneoplastic polyarthritis, or paraneoplastic rheumatic diseases. Abstracts, full articles, and selected references were reviewed. The aim of the present narrative review article was to describe the clinical characteristics, diagnostic evaluation, and management of paraneoplastic arthritides, and highlight the challenges that health care providers may encounter, distinguishing those conditions from other autoimmune rheumatic disorders. Future studies are needed to give insight into the mechanisms associated with paraneoplastic arthritides, leading to the development of novel diagnostic biomarkers.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflicts of interest.

Comment in

References

    1. Manger B, Schett G. Rheumatic paraneoplastic syndromes—a clinical link between malignancy and autoimmunity. Clin Immunol . 2018;186:67–70.
    1. Rast F, Parperis K, Amar S, et al. Paraneoplastic inflammatory arthritis. Cureus . 2018;10:e2663.
    1. Manger B, Schett G. Paraneoplastic syndromes in rheumatology. Nat Rev Rheumatol . 2014;10:662–670.
    1. Kisacik B, Onat AM, Kasifoglu T, et al. Diagnostic dilemma of paraneoplastic arthritis: case series. Int J Rheum Dis . 2014;17:640–645.
    1. Chandran G, Ahern MJ, Seshadri P, et al. Rheumatic manifestations of the myelodysplastic syndromes: a comparative study. Aust N Z J Med . 1996;26:683–688.

LinkOut - more resources